Professor
Hirslanden Private Hospital Group
Head of Aortic Centre
Aortic and Vascular Centre
Zurich, Switzerland
Presenter
SESSION 12: PROGRESS IN THE TREATMENT OF AORTIC AND AORTOILIAC OCCLUSIVE DISEASE; HYPOGASTRIC REVASCULARIZATION
Presenter
SESSION 40: MORE ADVANCES RELATED TO TREATING PATHOLOGY INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH; AORTIC DISSECTIONS, INTRAMURAL HEMATOMAS (IMHS) AND THEIR TREATMENT
Session Moderator
SESSION 52: MORE NEW DEVELOPMENTS IN TECHNIQUES OF ENDO TREATMENT OF RUPTURED AAAS, COMPLEX AAAS AND TAAAS; WHAT IS AND SHOULD BE HAPPENING WITH AAA SCREENING
SESSION 12: PROGRESS IN THE TREATMENT OF AORTIC AND AORTOILIAC OCCLUSIVE DISEASE; HYPOGASTRIC REVASCULARIZATION
The VORTEC Technique For Aortofemoral Bypass: What Is It And How To Do It: Why Is It Especially Valuable For Heavily Calcified And Scarred Aortas
10:30 AM - 10:35 AM
Presenter
SESSION 40: MORE ADVANCES RELATED TO TREATING PATHOLOGY INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH; AORTIC DISSECTIONS, INTRAMURAL HEMATOMAS (IMHS) AND THEIR TREATMENT
Updated 5-Year Results From The European Experience With The Novel Nexus Single And Double (Duo) Branched (OTS) Endovascular Devices (From Endospan) For The Treatment Of Zone 0 And 1 Aortic Arch Aneurysms: What Makes This Device Unique
8:33 AM - 8:38 AM
Session Moderator
SESSION 52: MORE NEW DEVELOPMENTS IN TECHNIQUES OF ENDO TREATMENT OF RUPTURED AAAS, COMPLEX AAAS AND TAAAS; WHAT IS AND SHOULD BE HAPPENING WITH AAA SCREENING